Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-08-25
1995-08-15
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514929, A61K 3156
Patent
active
054419476
ABSTRACT:
Wortmannin and certain of its analogs are inhibitors of restinosis.
REFERENCES:
patent: 3668222 (1972-06-01), Hauser
Kocher, et al., FEBS, 291:2, 363-366, (Oct. 1991).
Harrison, JACC, 17:6, 71B-76B, (May 1991).
Bankhead, Medical World News, 26-34 (Feb. 1991).
Hermans, et al., American Heart Journal, 122:1, 171-187 (Jul. 1991).
Liu, et al., TCM, 1:3, 107-111 (1991).
Circulation, 88:4, Part 2 (Oct. 1993), Abstract 2726.
JACC, Feb. 1994:1A-484A, Abstract 829-3.
Dewald, M. B. B., et al., Br. J. Pharmacol., 69(2): 269-270 (1980).
Bonser, R. W., et al., Br. J. Pharmacol 103(1): 1237-1241 (1991).
Wiesinger, D., et al., Experientia 30(2): 135-136 (1974).
Closse, A. et al., J. Med. Chem. 24(12): 1465-1471 (1981).
Reinhold, S. L., et al The FASEB Journal 4(2): 208-214 (1990).
Wymann, M. P., et al. The Journal of Biological Chemistry 264(27): 15829-15834 (1989).
Dewald, B. et al., The Journal of Biological Chemistry 263(31): 16179-16184 (1988).
Haeflinger, W., et al., Helv. Chem. Acta, 56(8): 2901-2904 (1973).
MacMillan, J., et al., J. Chem. Soc. Perkin I, 2892-2898 (1972).
Abbas, H. K. et al., Appl. Environ. Microbiol. 54(5): 1268-1274 (1988).
Nakanishi, S., et al., J. Biol. Chem., 267(4): 2157-2163 (1992).
Ohara-Imaizumi, M., et al., Biochem. Biophys. Res. Commun., 185(3): 1016-1021 (1992).
Coughlin, S. R., et al., Science, 243: 1191-1194 (1989).
Baggiolini, M., et al., Exp. Cell Res., 169: 408-418 (1987).
Matter, W. F., et al., Biochem. Biophys. Res. Commun. 186(2): 624-631 (1992).
Shibasaki, F., et al., J. Biol. Chem., 266(13): 8108-8114 (1991).
Kaplan, D. R. et al., Cell, 50: 1027-1029 (1987).
Valius, M., et al., Cell, 73: 321-334 (1993).
Dodge Jeffrey A.
Sato Masahiko
Caltrider Steven P.
Cintins Marianne M.
Dahling Gerald V.
Eli Lilly and Company
Sales James J.
LandOfFree
Methods of inhibiting vascular restenosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting vascular restenosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting vascular restenosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2181895